Synthesis and Antiviral Activity of 5‐Ethyl‐5‐halo‐6‐alkoxy‐(or Azido)‐5,6‐dihydro‐2′‐deoxyuridine Diastereomers as Potential Prodrugs to 5‐Ethyl‐2′‐deoxyuridine

Rakesh Kumar,L. Wiebe,E. Knaus
DOI: https://doi.org/10.1002/ardp.19973300806
Archiv der Pharmazie
Abstract:A group of 5‐ethyl‐5‐halo‐6‐alkoxy (or azido)‐5,6‐dihydro‐2′‐deoxyuridines, which differ in configuration at the C‐5 and C‐6 positions, were synthesized by the regiospecific addition of XR (X = I, Br, Cl; R = alkoxyl, azido) to the 5,6‐olefinic bond of 5‐ethyl‐2′‐deoxyuridine (EDU). In vitro antiviral (HSV‐1, HSV‐2, HCMV, VZV) activities were determined. Structure‐activity studies showed that the C‐5 halogeno (I, Br, Cl) and C‐6 alkoxy (OMe, OEt) or azido, substituents were determinants of antiviral activity where the (5R,6R)‐5 and (5S,6S)‐6 diastereomers of 5‐ethyl‐5‐iodo‐6‐methoxy‐5,6‐dihydro‐2′‐deoxyuridine exhibited greater potency against HSV‐1, HSV‐2, and HCMV than the related 5‐chloro‐6‐ethoxy and 5‐bromo (or chloro)‐6‐azido diastereomers. The most potent antiviral agents, (+)‐trans‐(5R,6R)‐5 and (−)‐trans‐(5S,6S)‐6 diastereomers of 5‐ethyl‐5‐iodo‐6‐methoxy‐5,6‐dihydro‐2′‐deoxyuridine were approximately 2‐to‐8 fold more potent than the reference drug EDU against HSV‐1 and HSV‐2.
What problem does this paper attempt to address?